Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) (IMA)
Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) is the official source of medicine shortage information for Iceland (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- lyfjastofnun.is
- Country
- Iceland
- Notices tracked by Mederti
- 2,838
- Last checked
- 2 Aug 2026
Latest notices from IMA
- Risperidonum — active, medium, since 1 Aug 2026 (source)
- Sitagliptin — active, medium, since 1 Aug 2026 (source)
- Simvastatinum — active, medium, since 1 Aug 2026 (source)
- Topiramatum — active, medium, since 1 Aug 2026 (source)
- Repaglinidum — active, medium, since 1 Aug 2026 (source)
- Alprazolamum — active, medium, since 31 Jul 2026 (source)
- Sitagliptinum — active, medium, since 31 Jul 2026 (source)
- Iodixanolum — active, medium, since 31 Jul 2026 (source)
- Takrólímus — active, low, since 31 Jul 2026 (source)
- Linezolidum — active, medium, since 31 Jul 2026 (source)
- Paracetamolum — active, medium, since 31 Jul 2026 (source)
- Octreotidum — active, low, since 30 Jul 2026 (source)
- Oxymetazolinum — active, low, since 30 Jul 2026 (source)
- Ribociclibum — active, medium, since 29 Jul 2026 (source)
- Ceftriaxonum — active, medium, since 28 Jul 2026 (source)
Every IMA notice, searchable and alertable
Search Iceland's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency). All notices remain the property of their publisher and are linked to the original source.